A core objective of D2R is to translate scientific discovery into real-world impact by supporting the development, scaling, and deployment of RNA-based innovations. To achieve this, the initiative has established a structured commercialization ecosystem that bridges academic research and industry application, ensuring that promising discoveries can progress efficiently from early-stage development to clinical and commercial pathways.
Through dedicated commercialization programs, D2R supports researchers in advancing RNA innovations by providing tailored expertise in:
- Business development
- Intellectual property management
- Entrepreneurship
- Startup creation
- Industry engagement
Within this framework, D2R supports principal investigators in advancing their research toward translational and commercialization milestones, while enabling industry partners to engage with cutting-edge science through research collaborations, targeted funding opportunities, and reduced barriers to partnership. Together, these complementary pathways form an integrated system that strengthens the connection between discovery and application, positioning D2R as a catalyst for RNA innovation and commercialization.
